F1ANNEX IIILIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED
5.Anti-inflammatory agents
5.1.Nonsteroidal anti-inflammatory agents
5.1.1.Arylpropionic acid derivative
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
Carprofen | Carprofen | Bovine | 500 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
500 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
1 000 μg/kg | Kidney | ||||
Equidae | 50 μg/kg | Muscle | |||
100 μg/kg | Fat | ||||
1 000 μg/kg | Liver | ||||
1 000 μg/kg | Kidney |
5.1.2.Enolic acid derivates
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
Meloxicam | Meloxicam | Bovine | 25 μg/kg | Muscle | Provisional MRLs expire on 1 January 2000 |
60 μg/kg | Liver | ||||
35 μg/kg | Kidney |
F25.1.3.Pyrazolone derivatives
Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
F3Metamizole | 4-Methylaminoantipyrin | Bovine, porcine, equidae | 200 μg/kg | Muscle | Provisional MRLs expire on 1.7.2003. Not for use in animals from which milk is produced for human consumption |
200 μg/kg | Fat | ||||
200 μg/kg | Liver | ||||
200 μg/kg | Kidney |
Substituted by Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin.